As geopolitical and economic risks rise, executives become more concerned. Proactive clients are taking action to boldly invest where it makes sense while aggressively focusing on inventory and cost reduction of non-value added items/ work and also ensuring high customer service levels.
Turbulent times are upon us. According to Reuters reporting from the Bank of America, geopolitics has leapfrogged inflation as the most significant risk to the market, and that was proven true as the market slumped with the expectation of Iran's attack on Israel.
You would have to be hiding under a rock to not hear that the market sold off. The S&P 500 sold off 3%; the Dow tumbled 1,000 points, and tech company leaders lost a combined $1 trillion intraday (recovering almost half later in the day).
If you follow the stock market, you might think the economy is strong. As consumers, we are frustrated with the price of everyday supplies such as food, gas, and housing.
Volatility, uncertainty, complexity, and ambiguity (VUCA) continues to rage and threaten manufacturers and supply chain chain organizations. The VUCA threshold skyrocketed during the pandemic, and it has not returned to normal.
Innovation is essential to thriving in today's volatile business environment. Drawing on lessons from QC Manufacturing and real-world experience, Lisa Anderson explains how innovation in people, culture, processes, and products drives growth, profitability, resilience, and long-term success.
Supply chain complexity continues to accelerate as organizations navigate geopolitical risk, talent shortages, technology disruption, and economic uncertainty. In this ASCM Orange County webinar, Lisa Anderson explores the top supply chain challenges facing manufacturers and distributors and outlines strategies to improve resiliency, predictability, profitability, and growth.
According to the ISM, "The Manufacturing PMI", a measure of manufacturing activity, registered at 48.5% in June, which is a decline from 48.7% in May.
The world faces economic headwinds. According to the Economist, Europe’s economy only grew at 4% this decade as compared with 8% of the United States and is struggling with a triple shock of the energy crisis, surging Chinese imports, and the threat of tariffs from the United States.
The medical device market is expected to grow by almost $178 billion from 2023 to 2027 according to Technavio. Moreover, a Fortune Business Insights Analysis estimates the market to reach $799 billion by 2030. With such significant growth, manufacturing and supply chains must scale and mitigate risk to ensure supplies to customers and patients.
